Pre-Morbid Risk Factors for Amyotrophic Lateral Sclerosis: Prospective Cohort Study

References

• Byrne S, Elamin M, Bede P, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012;11(3):232–240. doi:10.1016/S1474-4422(12)70014-522305801
   PubMed Web of Science ®Google Scholar
• Abhinav K, Stanton B, Johnston C, et al. Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology. 2007;29(1–2):44–48. doi:10.1159/00010891717898523
   PubMed Web of Science ®Google Scholar
• Marin B, Boumédiene F, Logroscino G, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46(1):57–74.27185810
   PubMed Web of Science ®Google Scholar
• Chiò A, Mora G, Moglia C, et al. Secular trends of amyotrophic lateral sclerosis: the Piemonte and valle d’aosta register. JAMA Neurol. 2017;74(9):1097–1104. doi:10.1001/jamaneurol.2017.138728692730
   PubMed Web of Science ®Google Scholar
• Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22(4):217–228. doi:10.1159/00007056212792141
   PubMed Web of Science ®Google Scholar
• Zhang L, Tang L, Huang T, Fan D. Life course adiposity and amyotrophic lateral sclerosis: a Mendelian randomization study. Ann Neurol. 2020;87(3):434–441. doi:10.1002/ana.2567131916305
   PubMed Web of Science ®Google Scholar
• Nakken O, Meyer HE, Stigum H, Holmøy T. High BMI is associated with low ALS risk: a population-based study. Neurology. 2019;93(5):e424–e32. doi:10.1212/WNL.000000000000786131243073
   PubMed Web of Science ®Google Scholar
• Alonso A, Logroscino G, Hernán MA. Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2010;81(11):1249–1252. doi:10.1136/jnnp.2009.18023220639382
   PubMed Web of Science ®Google Scholar
• Zhan Y, Fang F. Smoking and amyotrophic lateral sclerosis: a Mendelian randomization study. Ann Neurol. 2019;85(4):482–484. doi:10.1002/ana.2544330786056
   PubMed Web of Science ®Google Scholar
• Wang MD, Little J, Gomes J, Cashman NR, Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology. 2017;61:101–130.27377857
   PubMed Web of Science ®Google Scholar
• D’Ovidio F, Rooney JPK, Visser AE, et al. Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study. J Neurol Neurosurg Psychiatry. 2019;90(1):11–19.30076269
   PubMed Web of Science ®Google Scholar
• Meng E, Yu S, Dou J, et al. Association between alcohol consumption and amyotrophic lateral sclerosis: a meta-analysis of five observational studies. Neurol Sci. 2016;37(8):1203–1208. doi:10.1007/s10072-016-2575-027103621
   PubMed Web of Science ®Google Scholar
• Roberts AL, Johnson NJ, Chen JT, Cudkowicz ME, Weisskopf MG. Race/ethnicity, socioeconomic status, and ALS mortality in the United States. Neurology. 2016;87(22):2300–2308. doi:10.1212/WNL.000000000000329827742817
   PubMed Web of Science ®Google Scholar
• Åberg M, Nyberg J, Robertson J, et al. Risk factors in Swedish young men for amyotrophic lateral sclerosis in adulthood. J Neurol. 2018;265(3):460–470. doi:10.1007/s00415-017-8719-129285652
   PubMed Web of Science ®Google Scholar
• Tsai CP, Lee JK, Lee CT. Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis. J Neurol. 2019;266(9):2233–2243. doi:10.1007/s00415-019-09405-x31152300
   PubMed Web of Science ®Google Scholar
• D’Ovidio F, d’Errico A, Carnà P, Calvo A, Costa G, Chiò A. The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis. Eur J Neurol. 2018;25(1):164–170. doi:10.1111/ene.1346528921834
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9(11):617–628. doi:10.1038/nrneurol.2013.20324126629
   PubMed Web of Science ®Google Scholar
• Rusina R, Vandenberghe R, Bruffaerts R. Cognitive and behavioral Manifestations in ALS: beyond Motor System Involvement. Diagnostics. 2021;11(4):548.33808566
   PubMed Web of Science ®Google Scholar
• Chiò A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10(5–6):310–323. doi:10.3109/1748296080256682419922118
   PubMed Web of Science ®Google Scholar
• Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B. Epidemiology of amyotrophic lateral sclerosis: a review of literature. Rev Neurol (Paris). 2016;172(1):37–45. doi:10.1016/j.neurol.2015.11.00226727307
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi:10.1016/S0140-6736(07)61602-X18064739
   PubMed Web of Science ®Google Scholar
• Lassale C, Gaye B, Hamer M, Gale CR, Batty GD. Ethnic disparities in hospitalisation for COVID-19 in England: the role of socioeconomic factors, mental health, and inflammatory and pro-inflammatory factors in a community-based cohort study. Brain Behav Immun. 2020;88:44–49. doi:10.1016/j.bbi.2020.05.07432497776
   PubMed Web of Science ®Google Scholar
• Elovainio M, Hakulinen C, Pulkki-Raback L, et al. Contribution of risk factors to excess mortality in isolated and lonely individuals: an analysis of data from the UK Biobank cohort study. Lancet Public Health. 2017;2(6):e260–e6. doi:10.1016/S2468-2667(17)30075-028626828
   PubMed Web of Science ®Google Scholar
• Batty GD, Deary IJ, Luciano M, Altschul DM, Kivimaki M, Gale CR. Psychosocial factors and hospitalisations for COVID-19: prospective cohort study based on a community sample. Brain Behav Immun. 2020;89:569–578. doi:10.1016/j.bbi.2020.06.02132561221
   PubMed Web of Science ®Google Scholar
• Hamer M, Kivimaki M, Gale CR, Batty GD. Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: a community-based cohort study of 387,109 adults in UK. Brain Behav Immun. 2020;87:184–187. doi:10.1016/j.bbi.2020.05.05932454138
   PubMed Web of Science ®Google Scholar
• Celis-Morales CA, Lyall DM, Steell L, et al. Associations of discretionary screen time with mortality, cardiovascular disease and cancer are attenuated by strength, fitness and physical activity: findings from the UK Biobank study. BMC Med. 2018;16(1):77. doi:10.1186/s12916-018-1063-129792209
   PubMed Web of Science ®Google Scholar
• Hamer M, Gale CR, Kivimaki M, Batty GD. Overweight, obesity, and risk of hospitalization for COVID-19: a community-based cohort study of adults in the United Kingdom. Proc Natl Acad Sci U S A. 2020;117(35):21011–21013. doi:10.1073/pnas.201108611732788355
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–2572. doi:10.1001/jama.289.19.256012748199
   PubMed Web of Science ®Google Scholar
• Batty GD, Hamer M. Vascular risk factors, Framingham risk score, and COVID-19: community-based cohort study. Cardiovasc Res. 2020;116(10):1664–1665. doi:10.1093/cvr/cvaa17832674147
   PubMed Web of Science ®Google Scholar
• Hamer M, Gale CR, Batty GD. Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: population-based, prospective cohort study. Metabolism. 2020;112:154344. doi:10.1016/j.metabol.2020.15434432835758
   PubMed Web of Science ®Google Scholar
• Batty GD, McIntosh AM, Russ TC, Deary IJ, Gale CR. Psychological distress, neuroticism, and cause-specific mortality: early prospective evidence from UK Biobank. J Epidemiol Community Health. 2016;70(11):1136–1139. doi:10.1136/jech-2016-20726727520533
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613–621.19996233
   PubMed Web of Science ®Google Scholar
• Lowe B, Wahl I, Rose M, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1–2):86–95. doi:10.1016/j.jad.2009.06.01919616305
   PubMed Web of Science ®Google Scholar
• Deary IJ, Bedford A. Some origins and evolution of the EPQ-R (short form) Neuroticism and Extraversion items. Pers Individ Dif. 2011;50(8):1213–1217. doi:10.1016/j.paid.2011.02.011
   Web of Science ®Google Scholar
• Gale CR, Čukić I, Batty GD, McIntosh AM, Weiss A, Deary IJ. When is higher neuroticism protective against death? Findings from UK Biobank. Psychol Sci. 2017;28(9):1345–1357. doi:10.1177/095679761770981328703694
   PubMed Web of Science ®Google Scholar
• Davies G, Marioni RE, Liewald DC, et al. Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112 151). Mol Psychiatry. 2016;21(6):758–767. doi:10.1038/mp.2016.4527046643
   PubMed Web of Science ®Google Scholar
• Batty GD, Deary IJ, Gale CR. Pre-pandemic cognitive function and COVID-19 mortality: prospective cohort study. Eur J Epidemiol. 2021;36(5):559–564. doi:10.1007/s10654-021-00743-733893922
   PubMed Web of Science ®Google Scholar
• Deary IJ, Der G, Ford G. Reaction times and intelligence differences: a population-based cohort study. Intelligence. 2001;29:389–399. doi:10.1016/S0160-2896(01)00062-9
   Web of Science ®Google Scholar
• Abell JG, Lassale C, Batty GD, Zaninotto P. Risk factors for hospital admission after a fall: a prospective cohort study of community-dwelling older people. J Gerontol a Biol Sci Med Sci. 2021;76(4):666–674. doi:10.1093/gerona/glaa25533021638
   PubMed Web of Science ®Google Scholar
• Cox DR. Regression models and life-tables. J R Stat Soc. 1972;34:187–220.
   Google Scholar
• Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181–193.25709501
   PubMed Web of Science ®Google Scholar
• Oskarsson B, Gendron TF, Staff NP. Amyotrophic lateral sclerosis: an update for 2018. Mayo Clin Proc. 2018;93(11):1617–1628. doi:10.1016/j.mayocp.2018.04.00730401437
   PubMed Web of Science ®Google Scholar
• Batty GD, Russ TC, Starr JM, Stamatakis E, Kivimaki M. Modifiable cardiovascular disease risk factors as predictors of dementia death: pooling of ten general population-based cohort studies. J Negat Results Biomed. 2014;13:8. doi:10.1186/1477-5751-13-824886432
   PubMedGoogle Scholar
• Killin LO, Starr JM, Shiue IJ, Russ TC. Environmental risk factors for dementia: a systematic review. BMC Geriatr. 2016;16(1):175. doi:10.1186/s12877-016-0342-y27729011
   PubMed Web of Science ®Google Scholar
• Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JPA, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement. 2017;13(4):406–418. doi:10.1016/j.jalz.2016.07.15227599208
   PubMed Web of Science ®Google Scholar
• Batty GD, Barzi F, Woodward M, et al. Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration. Ann Oncol. 2010;21(3):646–654. doi:10.1093/annonc/mdp36319889610
   PubMed Web of Science ®Google Scholar
• Lee CM, Barzi F, Woodward M, et al. Adult height and the risks of cardiovascular disease and major causes of death in the Asia-Pacific region: 21,000 deaths in 510,000 men and women. Int J Epidemiol. 2009;38(4):1060–1071. doi:10.1093/ije/dyp15019270305
   PubMed Web of Science ®Google Scholar
• Whalley LJ, Dick FD, McNeill G. A life-course approach to the aetiology of late-onset dementias. Lancet Neurol. 2006;5(1):87–96. doi:10.1016/S1474-4422(05)70286-616361026
   PubMed Web of Science ®Google Scholar
• Russ TC, Kivimaki M, Starr JM, Stamatakis E, Batty GD. Height in relation to dementia death: individual participant meta-analysis of 18 UK prospective cohort studies. Br J Psychiatry. 2014;205(5):348–354. doi:10.1192/bjp.bp.113.14298425368359
   PubMed Web of Science ®Google Scholar
• Batty GD, Shipley MJ, Gunnell D, et al. Height, wealth, and health: an overview with new data from three longitudinal studies. Econ Hum Biol. 2009;7(2):137–152. doi:10.1016/j.ehb.2009.06.00419628438
   PubMed Web of Science ®Google Scholar
• Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. doi:10.1371/journal.pmed.100177925826379
   PubMed Web of Science ®Google Scholar
• Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017;186(9):1026–1034. doi:10.1093/aje/kwx24628641372
   PubMed Web of Science ®Google Scholar
• Batty GD, Gale CR, Kivimäki M, Deary IJ, Bell S. Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BMJ. 2020;1:368.
   Google Scholar
• Lassale C, Hamer M, Hernáez Á, Gale CR, Batty GD. Association of pre-pandemic high-density lipoprotein cholesterol with risk of COVID-19 hospitalisation and death: the UK Biobank cohort study. Prev Med Rep. 2021;23:101461. doi:10.1016/j.pmedr.2021.10146134178592
   PubMedGoogle Scholar